The research group of Univ. Prof. Dr. Thomas Reiberger, focuses on clinical portal hypertension and liver cirrhosis.
The main goal is the development and research of pathophysiologically oriented new therapeutic approaches for portal hypertension and its complications.
Prof. PD Dr. Thomas Reiberger
Scientific physicianIf you have any questions about research activities, the possibility of working together, diploma theses, cooperations, scientific events, internships, please send an email to: thomas.reiberger@meduniwien.ac.at
- > 100 original papers on liver cirrhosis and portal hypertension
- national and international collaborations
- interdisciplinary research collaborations
- translational research in collaboration with the HEPEX laboratory
- Exploration of new drug therapy options for portal hypertension
- Evaluation of non-invasive prognostic parameters (biomarkers) for clinical assessment of patients with liver cirrhosis